CQENS Technologies moved the exercise periods for its 7,000,000-share Series A and Series B warrants to September 30, 2029 through September 30, 2032. Investors now have a revised exercise timetable to assess alongside the unchanged $5.31 per-share price and the aggregate 21,000,000-warrant package.
Key Highlights
- CQENS Technologies’ warrants carry an exercise price of $5.31 per share.
- The company’s Warrant package covers an aggregate of 21,000,000 common stock warrants.
- CQENS Technologies may accelerate commencement or extend expiration dates by notifying Xten Capital Group.
Xten Capital Group agreed to delay the Series B timetable in exchange for extending Series A on the same schedule. The amendment changes when those warrants can be exercised while preserving the $5.31 per-share exercise price and other terms that were not specifically modified. The warrants originated in connection with CQENS Technologies’ 2020 purchase of intellectual property Assets from Xten, which the company identified as a related party. The consideration included warrants covering an aggregate of 21,000,000 shares of common stock, with Series A, Series B and Series C instruments each exercisable for 7,000,000 shares. The Series C warrant’s stated exercise period runs from September 30, 2029 through September 30, 2032.
Series A and Series B Terms Rewritten
CQENS Technologies’ board approved the amendment effective September 3, 2026. The revised Series A period begins September 30, 2029 and ends September 30, 2032, while the revised Series B period follows the same dates. CQENS Technologies may accelerate the start of either exercise period or extend its expiration date by notifying Xten. The amendment controls if its terms conflict with the warrants, and provisions not specifically changed remain preserved. William P. Bartkowski signed for CQENS Technologies as secretary and chief administrative officer, while Alexander Chong signed for Xten as chairman and chief executive officer.
FAQs
Q: What changed in CQENS Technologies’ Series A and Series B warrants?
A: CQENS Technologies moved both warrant exercise periods to September 30, 2029 through September 30, 2032. Xten Capital Group agreed to the revised timing.
Q: What is the CQENS Technologies warrant exercise price?
A: The common stock purchase warrants retain an exercise price of $5.31 per share. The amendment changed exercise timing for Series A and Series B.
Q: How many CQENS Technologies warrants are covered?
A: The warrants cover an aggregate of 21,000,000 common-stock shares. Series A, Series B and Series C each represent warrants exercisable for 7,000,000 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.